tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ATRA Stock Latest News

Atara Biotherapeutics Announces CFO Departure and New Appointment
Company AnnouncementsAtara Biotherapeutics Announces CFO Departure and New Appointment
28d ago
8K
ATRA
Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement
PremiumRatings
Atara Biotherapeutics: Strategic Focus on Ebvallo BLA Resubmission and Market Position Enhancement
2M ago
ATRA
Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes
PremiumCompany Announcements
Atara Biotherapeutics Faces Potential Liquidation: Strategic Decisions Crucial for Investor Outcomes
2M ago
ATRA
Atara Biotherapeutics Reports 2024 Financial Results
PremiumCompany Announcements
Atara Biotherapeutics Reports 2024 Financial Results
2M ago
ATRA
Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year
PremiumThe Fly
Atara Biotherapeutics reports Q4 EPS ($1.19) vs. ($14.00) last year
2M ago
ATRA
ATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsATRA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ATRA
Atara reduction in workforce to impact 50% of current employees
Premium
The Fly
Atara reduction in workforce to impact 50% of current employees
3M ago
ATRA
Atara Biotherapeutics price target lowered to $5 from $10 at Stifel
Premium
The Fly
Atara Biotherapeutics price target lowered to $5 from $10 at Stifel
3M ago
ATRA
Atara Biotherapeutics downgraded to Neutral from Buy at Rodman & Renshaw
PremiumThe Fly
Atara Biotherapeutics downgraded to Neutral from Buy at Rodman & Renshaw
3M ago
ATRA
Atara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219
PremiumThe Fly
Atara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219
3M ago
ATRA
Atara Biotherapeutics price target lowered to $17 from $21 at Canaccord
PremiumThe Fly
Atara Biotherapeutics price target lowered to $17 from $21 at Canaccord
3M ago
ATRA
Atara Biotherapeutics trading resumes
PremiumThe Fly
Atara Biotherapeutics trading resumes
3M ago
ATRA
Atara Biotherapeutics remains eligible for $60M milestone payment
PremiumThe FlyAtara Biotherapeutics remains eligible for $60M milestone payment
3M ago
ATRA
Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
Premium
The Fly
Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
3M ago
ATRA
Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
Premium
The Fly
Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
3M ago
ATRA
Atara Biotherapeutics trading halted, news pending
PremiumThe Fly
Atara Biotherapeutics trading halted, news pending
3M ago
ATRA
Twelve option delistings on December 23rd
PremiumThe Fly
Twelve option delistings on December 23rd
4M ago
ATRA
BURU
Atara Biotherapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Atara Biotherapeutics initiated with a Buy at Rodman & Renshaw
4M ago
ATRA
Atara Biotherapeutics Reports Q3 2024 Financial Progress
PremiumCompany Announcements
Atara Biotherapeutics Reports Q3 2024 Financial Progress
6M ago
ATRA
Atara Biotherapeutics price target raised to $21 from $13 at Canaccord
PremiumThe FlyAtara Biotherapeutics price target raised to $21 from $13 at Canaccord
6M ago
ATRA
Atara Biotherapeutics Advances with Strategic Partnerships
Premium
Company Announcements
Atara Biotherapeutics Advances with Strategic Partnerships
6M ago
8K
ATRA
Atara Biotherapeutics reports Q3 EPS ($2.93), consensus ($1.93)
Premium
The Fly
Atara Biotherapeutics reports Q3 EPS ($2.93), consensus ($1.93)
6M ago
ATRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >